Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 12/01/20221 min de lecture
Determination of Regulatory Review Period for Purposes of Patent Extension; ENHERTU; Correction
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA or the Agency) published a notice in the Federal Register of November 1, 2021, for the determination of a regulatory review period for purposes of patent extension for the human biological product, ENHERTU. This document corrects that notice by adjusting the applicable regulatory review period for the testing phase and approval phase of the product, ENHERTU.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →